About 400 reports

  • Systemic Autoimmune Diseases Diagnostics
  • Localized Autoimmune Disease Diagnostics

© IGATE RESEARCH PAGE ## OF ## Global Autoimmune Disease Diagnostics Market - Overview The global autoimmune disease diagnostics market is expected to reach nearly US$ ## Billion by 2026.

  • Autoimmune Disease
  • World
  • Market Size
  • bioMerieux S.A.
  • Roche Group

EXECUTIVE SUMMARY ##.

  • Autoimmune Disease
  • Pathology
  • APAC
  • World
  • Market Shares

Autoimmune Disease Diagnostics Market Intelligence Report - Global Forecast to 2025 ##.

  • Autoimmune Disease
  • Diagnostics
  • United States
  • World
  • Market Size

On the basis of Indication, the Global Autoimmune Disease Drug Market is studied across Diabetes Mellitus Type ##, Multiple Sclerosis, Rare Diseases, and Rheumatic Diseases.

  • Autoimmune Disease
  • Pathology
  • World

Global Autoimmune Disease Therapeutics Market (2019-2025) Global Autoimmune Disease Therapeutics Market Chapter ##.

  • Autoimmune Disease
  • Therapy
  • North America
  • United States
  • Market Size

GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX List of Tables TABLE ##.

  • Autoimmune Disease
  • Diagnostics
  • Pathology
  • United States
  • Market Size

Autoimmune Disease Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Autoimmune Disease
  • Diagnostics
  • APAC
  • World
  • Market Size

Autoimmune Disease Therapeutics Market by Drug Class, Indication and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025 CHAPTER ##: INTRODUCTION ##. ##.

  • Autoimmune Disease
  • Therapy
  • APAC
  • Forecast
  • Market Size

Growth Drivers for Autoimmune Disease Diagnostic ##. ## Point No. ## ##. ## Point No. ## ##.

  • Autoimmune Disease
  • World
  • Company Financials
  • Forecast
  • Market Shares

Europe Autoimmune Disease Therapeutics Market (2019-2025) Europe Autoimmune Disease Therapeutics Market Chapter ##.

  • Autoimmune Disease
  • Pathology
  • Therapy
  • Europe
  • Market Size

Asia Pacific Autoimmune Disease Therapeutics Market (2019-2025) Asia Pacific Autoimmune Disease Therapeutics Market Chapter ##.

  • Autoimmune Disease
  • Pathology
  • Therapy
  • APAC
  • Market Size

North America Autoimmune Disease Therapeutics Market (2019-2025) North America Autoimmune Disease Therapeutics Market Chapter ##.

  • Autoimmune Disease
  • Therapy
  • North America
  • United States
  • Market Size

Latin America, Middle East & Africa Autoimmune Disease Therapeutics Market (2019-2025) LAMEA Autoimmune Disease Therapeutics Market Chapter ##.

  • Autoimmune Disease
  • Pathology
  • Pharmaceutical
  • Therapy
  • Market Size

Autoimmune Disease Diagnostics Market: The global Industry Analysis, Trends, Market Size and Forecasts up to 2023 ##.

  • Autoimmune Disease
  • Diagnostics
  • World
  • Market Size
  • PREVALENCE OF DIAGNOSED AUTOIMMUNE DISEASES,
  • GLOBAL PREVALENCE OF DIABETES TYPE II,

SUPPLIER POWER - LOW ##.

  • Autoimmune Disease
  • World
  • OptiBiotix Health plc
  • PureTech LLC
  • Ritter Pharmaceuticals, Inc.
  • Autoimmune diseases
  • 3.2 RISK FACTORS AND COMORBIDITIES

The most common comorbidities associated with AA are autoimmune diseases, thyroid diseases, atopic diseases, nail changes, and psychological disorders. ##. ## RISK FACTORS AND COMORBIDITIES Table ##: Risk Factors and Comorbidities for AA The risk of AA declin

  • Autoimmune Disease
  • Epidemiology
  • Pathology
  • United States
  • Forecast
  • Autoimmune diseases
  • 5.2 RISK FACTORS AND COMORBIDITIES

There have been many reports of an association between AA and autoimmune diseases.

  • Autoimmune Disease
  • Therapy
  • United States
  • Forecast
  • Pfizer Inc.
  • OPPORTUNITY 2 EXTENSION INTO OTHER AUTOIMMUNE DISEASES SUCH AS ASTHMA AND PSA
  • 12.1 BIBLIOGRAPHY

OPPORTUNITY ## EXTENSION INTO OTHER AUTOIMMUNE DISEASES SUCH AS CD AND PSORIATIC ARTHRITIS.

  • Autoimmune Disease
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Pfizer Inc.
  • Remicade group
  • PROTEOMICS APPROACH: AUTOIMMUNE DISEASE BIOMARKER DISCOVERY
  • AUTOIMMUNE DISORDERS

Fig ## PARADIGM SHIFT: RX TO CDX Fig ## ## ## ## ## ## ## ADVANCEMENTINTHERAPYAREAS ANALYSIS Sense and Response Predict and Act?

  • Autoimmune Disease
  • North America
  • United States
  • World
  • Market Size

## Country share estimation TABLE ## List of NIH funding programs, 2013 TABLE ## Potential biomarkers and their potential applications in treating SLE TABLE ## ITP prevalence, by condition TABLE ## North America autoimmune disease diagnostics market, by type, 2013 - 2025 (USD M

  • Autoimmune Disease
  • Diagnostics
  • Pathology
  • United States
  • Market Size
  • GLOBAL AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 7.5.2 Global Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

Autoimmune disease is one of the fastest-growing causes of disability and death in the US has been strongly connected to the health of the human microbiota.

  • Autoimmune Disease
  • World
  • Forecast
  • Market Size
  • MicroBiome Therapeutics LLC

AXSPA IS AN AUTOIMMUNE DISEASE THAT HAS A SIGNIFICANT GENETIC SUSCEPTIBILITY COMPONENT, WITH ENVIRONMENTAL FACTORS LIKELY CONTRIBUTING TO CHRONIC INFLAMMATION.

  • Autoimmune Disease
  • United States
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT
  • AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION

Grifols is one of the leading companies in the autoimmune disease diagnosis market.

  • Autoimmune Disease
  • Immunodiagnostics
  • North America
  • United States
  • Abbott
  • AUTOIMMUNE DISEASES
  • GLOBAL IMMUNOSUPPRESSANTS MARKET

Autoimmune diseases include a broad spectrum of diseases that can affect any body part.

  • Autoimmune Disease
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

ONE KOL NOTED THAT THE RARE USAGE OF REFERENCE PRODUCTS IS TYPICALLY LIMITED TO PATIENTS WITH UNSTABLE DISEASE, IN WHICH DISEASE FLARES ARE OF CONCERN.

  • Autoimmune Disease
  • AbbVie Inc.
  • Amgen Inc.
  • Novartis AG
  • Pfizer Inc.

Appendix ## ##. ## Primary Research ## ##. ## Sources ## ##. ## About the Authors ## ##. ## About GlobalData ## ##. ## Contact Us ## ##. ## Disclaimer ## REPORT SCOPE Disease Scope THIS REPORT INCLUDES BIOSIMILARS (MARKETED AND IN PIPELINE) FOR MAJOR AUTOIMMUNE DISEASE INDICATI

  • Autoimmune Disease
  • Biocon Limited
  • Biogen Idec Inc.
  • Mylan Inc.
  • Pfizer Inc.
  • Increased prevalence of autoimmune diseases
  • Limitations of autoimmune disease diagnostics

Rheumatoid arthritis SLE Market drivers Increased prevalence of autoimmune diseases Type ## diabetes is a localized autoimmune disease.

  • Autoimmune Disease
  • Forecast
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Thermo Fisher Scientific, Inc.
  • 2.7 Co-morbidities and Complications
  • 2.1 Therapy Area Overview

Autoimmune Diseases.

  • Autoimmune Disease
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Fibrocell Science, Inc.

Autoimmune Disease Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 ##.

  • Autoimmune Disease
  • Diagnostics
  • Pathology
  • World
  • Market Size
  • INCREASE IN PUBLIC AWARENESS PROGRAMS
  • Global Vasculitis Treatment Market is Expected to Grow to $517.64 mn by 2021

You can easily book an appointment with one online.

  • Autoimmune Disease
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc